The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial intelligence, when developing monoclonal antibody therapies and other drugs.
Original Image Link
Source:www.upi.com
Original Image Link
Source:www.upi.com
Posted: 2025-04-10 03:45:00